The European consortium for Solving the Unsolved Rare Diseases has demonstrated the significance of international collaboration to address the unmet medical needs for rare diseases' diagnosis. More than 500 European patients ...
Jan 17, 2025
0
139
A new study that identified 475 patients with post-acute sequelae of COVID-19 (PASC), also known as long COVID, revealed that nearly 85% (403) of these patients had multiple COVID-19 infections over the course of a four-year ...
Jan 16, 2025
0
123
Researchers at Oregon Health & Science University have uncovered how a molecule found on certain bacteria may drive blood clotting in sepsis, a life-threatening condition that causes about 8 million deaths per year.
Jan 17, 2025
0
26
Whether COVID-19 was unleashed by a laboratory mishap or spilled over from animals remains an enduring, fiercely contested mystery.
20 hours ago
0
71
In early December 2024, a group of researchers published an article in the journal Science, entitled "A single mutation in bovine influenza H5N1 hemagglutinin switches specificity to human receptors". Some media outlets somewhat ...
Jan 14, 2025
0
14
Studies conducted in mice have shown that the COVID-19 vaccine being developed by researchers at the University of São Paulo's Medical School (FM-USP) in Brazil is safe and efficacious. The vaccine triggered a satisfactory ...
Jan 13, 2025
0
73
One of the earliest strains of bird flu isolated from a human in Texas shows a unique constellation of mutations that enable it to more easily replicate in human cells and cause more severe disease in mice compared to a strain ...
Jan 15, 2025
0
34
Not many people had heard of human metapneumovirus, or HPMV, until a surge of recent cases in China made headlines.
Jan 13, 2025
0
0
Six-month outcomes of children and adolescents diagnosed with multisystem inflammatory syndrome in children (MIS-C) after COVID-19 infection show normalization of cardiac function and return to nearly full baseline health ...
A clinical trial published in the New England Journal of Medicine showed that the oral antibiotic levofloxacin taken once-daily for six months substantially reduced the risk of developing drug-resistant tuberculosis (TB), ...
Jan 15, 2025
0
22
